Live News EQUITY FLASH L impact Oct 12, 2026, 12:30 PM UTC Leerink Partners Announces $130 Price Target for Nektar Therapeutics Leerink Partners announced a $130.00-per-share price target for Nektar Therapeutics. NKTR SquawkNews Desk